Clinical trial
A Multi-Centre Randomised Study Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for Taxane- Associated Pain Syndrome (TAPS) in Breast Cancer Patients (OTT 17-02 REaCT-TAPS)
NCT03348696 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Centre Randomised Study Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for Taxane- Associated Pain Syndrome (TAPS) in Breast Cancer Patients (OTT 17-02 REaCT-TAPS)
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2018
- Completion date
- April 2, 2019
- Enrollment
- 124 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
early-stage breast cancer, pain syndrome